Team:Paris Bettencourt/Human Practice/Overview
From 2012.igem.org
(Difference between revisions)
Line 28: | Line 28: | ||
#:* The compiling of the wiki screen shows that '''''no containment systems created in iGEM is robust''''': they are all one mutation away from failure. We call for more biosafety in iGEM (F), | #:* The compiling of the wiki screen shows that '''''no containment systems created in iGEM is robust''''': they are all one mutation away from failure. We call for more biosafety in iGEM (F), | ||
#:* '''''The need for an INDEPENDENT committee of scientists''''' to test any application of synthetic biology that requires releasing in the environment (G), | #:* '''''The need for an INDEPENDENT committee of scientists''''' to test any application of synthetic biology that requires releasing in the environment (G), | ||
- | You can find the full list [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Report here] | + | You can find the full list of conclusions [https://2012.igem.org/Team:Paris_Bettencourt/Human_Practice/Report here] |
''Main Proposals'' | ''Main Proposals'' |
Revision as of 22:10, 26 September 2012
Human Practice
Aim To chart new venues of best practice for synthetic biology. To this end, we examined the ethical, biological and social concerns related to the release of genetically modified bacteria in the wild. Metodology
You can find the full list of conclusions here Main Proposals
|